82 FR 21256 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 86 (May 5, 2017)

[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21256-21257]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09052]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee J--Career Development.
    Date: June 13-14, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources & Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH 9609 Medical Center 
Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03.
    Date: June 15-16, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-7286, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP-9.
    Date: June 19-20, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology & Contract Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Research Specialist--R50.
    Date: June 22-23, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP 5.
    Date: June 23, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jennifer C Schiltz, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-8.
    Date: June 28-29, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Eduardo E Chufan, Ph.D., Scientific Review 
Officer, Research Technology & Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-1.
    Date: June 28, 2017.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Ivan Ding, MD, Health Scientist Administrator, 
Program & Review Extramural Staff Training Office, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular and Cellular Analysis.
    Date: June 30, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W634, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PDX Development and Trial Centers RFA CA-17-003 (U54) & RFA 
CA-17-004 (U24).
    Date: July 11-12, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantitative Imaging to Evaluate Response to Cancer Therapy.
    Date: July 12, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W030, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 21257]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: May 1, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09052 Filed 5-4-17; 8:45 am]
 BILLING CODE 4140-01-P